Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/108835
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAbobarin-Adeagbo, Abimbola-
dc.contributor.authorWienke, Andreas-
dc.contributor.authorGirndt, Matthias-
dc.contributor.authorPliquett, Rainer U.-
dc.date.accessioned2023-07-05T12:19:40Z-
dc.date.available2023-07-05T12:19:40Z-
dc.date.issued2020-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/110790-
dc.identifier.urihttp://dx.doi.org/10.25673/108835-
dc.description.abstractBackground: Aim of this study is to investigate a possible association of hypoglycemic episodes and arterial hypertension. We hypothesize that hospitalized insulin-treated diabetes patients with hypertensive crisis have more hypoglycemic episodes than their counterparts without hypertensive crisis on admission. Methods: In a prospective, observational cohort study, 65 insulin-treated diabetes patients (type 1, type 2, type 3c) were included in Group 1, when a hypertensive crisis was present, as control patients in Group 2 without hypertensive crisis or hypoglycemia, in Group 3, when a symptomatic hypoglycemia was present on admission. All patients were subjected to open-label continuous glucose monitoring, 24-h blood-pressure- and Holter electrocardiogram recordings, and to laboratory tests including plasma catecholamines. Results: 53 patients, thereof 19 Group-1, 19 Group-2, 15 Group-3 patients, completed this study. Group-1 patients had the highest maximum systolic blood pressure, a higher daily cumulative insulin dose at admission, a higher body-mass index, and a higher plasma norepinephrine than control patients of Group 2. Group-3 patients had more documented hypoglycemic episodes (0.8 ± 0.5 per 24 h) than Group-2 patients (0.2 ± 0.3 per 24 h), however, they were not different to the ones in Group-1 patients (0.4 ± 0.4 per 24 h). Plasma norepinephrine and mean arterial blood pressure were higher Group-1 and Group-3 patients than in control patients of Group 2. At discharge, the daily cumulative insulin dose was reduced in Group-1 (− 18.4 ± 24.9 units) and in Group-3 patients (− 18.6 ± 22.7 units), but remained unchanged in Group-2 control patients (− 2.9 ± 15.6 units). Conclusions: An association between hypoglycemic events and uncontrolled hypertension was found in this study.eng
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.ddc610-
dc.titleGlycopenia - induced sympathoadrenal activation in diabetes mellitus and uncontrolled arterial hypertension : an observational studyeng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleDiabetology & metabolic syndrome-
local.bibliographicCitation.volume12-
local.bibliographicCitation.publishernameBioMed Central-
local.bibliographicCitation.publisherplaceLondon-
local.bibliographicCitation.doi10.1186/s13098-020-00613-4-
local.subject.keywordsArterial hypertension, norepinephrine, hypoglycemia, diabetes mellitus-
local.openaccesstrue-
dc.identifier.ppn1755150539-
local.bibliographicCitation.year2020-
cbs.sru.importDate2023-07-05T12:18:49Z-
local.bibliographicCitationEnthalten in Diabetology & metabolic syndrome - London : BioMed Central, 2009-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
s13098-020-00613-4.pdf1.1 MBAdobe PDFThumbnail
View/Open